December 12, 2016 / 12:39 PM / in 7 months

BRIEF-Kalobios completes meeting with FDA for benznidazole

1 Min Read

Dec 12 (Reuters) - Kalobios Pharmaceuticals Inc:

* Kalobios completes meeting with FDA for Benznidazole

* Kalobios Pharmaceuticals-recently completed meeting with U.S. FDA to review its proposed development plans for benznidazole

* Kalobios Pharmaceuticals - FDA's division addressed Co's questions, provided guidance on preparation of acceptable package for benznidazole Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below